Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease

The objectives of this study are to investigate issues or questions about MIRAPEX Tablets as shown below through the Post Marketing Surveillance (PMS) study upon approval. * Unexpected adverse events (especially, serious adverse events (SAEs)) * To find out the status of incidence of adverse events under actual practice * Factors on the safety profile * Factors on the efficacy profile